Poolbeg Pharma PLC has announced the grant of its first national patent covering the POLB-001 programme, which addresses cytokine release syndrome induced by cancer immunotherapy. The development represents a significant
Pharmaceutical2- Page
197Articles
<p>The National Institute for Health and Care Excellence (NICE) has recommended that semaglutide, the active compound marketed under the brand names Wegovy and Ozempic, be prescribed to more than one
The successful commercial deployment of a newly approved grass pollen immunotherapy is expected to establish a foundation for long-term profitability at Allergy Therapeutics PLC, according to broker analysis from Cavendish.
Shares in Poolbeg Pharma PLC climbed as much as 10% during Tuesday morning trading following confirmation that the company has secured its first national patent grant for POLB 001, its
Bayer has halted the acceptance of new patients into its early access scheme, amidst an ongoing dispute with HMRC regarding tax liabilities on free-of-charge medicines. This decision has raised concerns
HeliosX, the London-based online pharmacy, has made significant strides in the weight-loss drug market, recently boasting a remarkable reduction of 8.5 million kilograms in patient weight, equating to approximately 3.5
Recent developments regarding Iran’s threats to close the Strait of Hormuz have sparked significant concerns among pharmacists and healthcare professionals in the UK. As a crucial maritime route for oil
Novo Nordisk, Denmark’s leading pharmaceutical company known for its weight management medications, has encountered significant economic hurdles recently. After achieving initial success with its medications Wegovy and Ozempic, the company
Hikma Pharmaceuticals, a leading FTSE 100 company in the pharmaceuticals sector, has seen a significant decline in its share price following the announcement of weaker financial forecasts and the scrapping
GSK has announced a significant acquisition, reaching a deal worth $950 million to purchase 35Pharma, a Canadian biopharmaceutical company with a focus on developing therapies for lung diseases linked to
A head-to-head trial of Novo Nordisk’s next-generation obesity drug, CagriSema, has revealed disappointing results in comparison to rival Eli Lilly’s Mounjaro. The trial results have triggered a significant sell-off in
Santhera Pharmaceuticals has released eight year clinical data for its Duchenne muscular dystrophy treatment Agamree that could fundamentally alter therapeutic approaches to this devastating condition, yet market recognition of this
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has clarified the rationale behind its recent announcement regarding share issuance authority ahead of its annual general meeting, emphasising that the move is designed
A subsidiary of AstraZeneca in China, along with a former leading executive and a senior employee, has been indicted on various charges by the prosecutor in Shenzhen. The investigation has
Citi has increased its price target for GSK PLC (LSE:GSK, NYSE:GSK) to £22.50 whilst maintaining a neutral rating on the pharmaceutical group following a notable rally in the shares driven
The Danish pharmaceutical company Novo Nordisk has seen its shares decline by nearly 50 per cent over the past year, following a warning of a significant drop in profits and
